Press release
Endoscopic Retrograde Cholangiopancreatography/ERCP Market worth $2.0 billion by 2026

ERCP Market by Product (Upper GI endoscopes, Stent, Balloons, Catheters, Baskets), Procedure (Biliary Sphincterotomy & Stenting, Pancreatic Sphincterotomy), End User (Hospitals) - Global Forecast to 2026
According to the new market research report "Endoscopic Retrograde Cholangiopancreatography/ERCP Market [https://www.marketsandmarkets.com/Market-Reports/endoscopic-retrograde-cholangiopancreatography-ercp-market-170242954.html?utm_source=abnewswire.com&utm_medium=referral&utm_campaign=ercpmarket] by Product (Upper GI endoscopes, Stent, Balloons, Catheters, Baskets), Procedure (Biliary Sphincterotomy & Stenting, Pancreatic Sphincterotomy), End User (Hospitals) - Global Forecast to 2026", published by MarketsandMarkets Trademark , the global Endoscopic Retrograde Cholangiopancreatography Market is projected to reach USD 2.0 billion by 2026 from USD 1.3 billion in 2021, at a CAGR of 9.6% during the forecast period.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=170242954 [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=170242954&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=ercpmarket]
The growth of this ERCP market is majorly attributed to factors such as the rising incidence of cancer, increasing investments by governments and healthcare organizations to improve endoscopy research, growing focus on investments by hospitals for advanced endoscopy instruments, and the increasing preference for minimally invasive surgeries. On the other hand, the high costs of endoscopic retrograde cholangiopancreatography devices, the development of other procedures like EUS and MRCP, and the shortage of trained physicians and endoscopists are factors expected to restrain the market growth to a certain extent.
By product type segment, the endotherapy devices segment accounted for the largest market share during the forecast period.
Based on products, the endoscopic retrograde cholangiopancreatography market has been segmented into endoscopes, endotherapy devices, visualization systems, energy devices, and others. The factors attributing to the large revenue of the endotherapy devices segment include the growing preference for minimally invasive surgeries and the increasing prevalence of gastrointestinal conditions.
Sphincterotomes accounted for the largest market share in the conventional devices segment during the forecast period.
In the endotherapy devices segment, sphincterotomes accounted for the largest market share during the forecast period. This can be attributed to the increasing incidence of pancreatic duct and bile duct stones and the growing geriatric population leading to an increase in biliary disorders.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=170242954 [https://www.marketsandmarkets.com/requestsampleNew.asp?id=170242954&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=ercpmarket]
North America dominates the endoscopic retrograde cholangiopancreatography market during the forecast period.
North America accounted for the largest share of the ERCP market in 2020. The increasing prevalence of cancer, high investments by hospitals to purchase new ERCP equipment, and a strong focus on research activities to improve endoscopy techniques are the major factor contributing to this.
The major players in the global endoscopic retrograde cholangiopancreatography market include Olympus Corporation (Japan), CONMED Corporation (US), Fujifilm Holdings Corporation (Japan), HOYA Corporation (Japan), KARL STORZ SE & Co. KG (Germany), Ambu A/S (Denmark), Boston Scientific Corporation (US), Johnson & Johnson (US), Medtronic, PLC (Ireland), Cook Medical (US), and B. Braun Melsungen AG (Germany).
Other players in the endoscopic retrograde cholangiopancreatography market include Hobbs Medical, Inc. (US), STERIS PLC (US), Merit Medical Systems, Inc. (US), TeleMed Systems, Inc. (US), Changzhou Health Microport Medical Device Co., LTD. (China), Medi-Globe GmbH (Germany), Taewoong Medical Co., Ltd. (South Korea), Huger Medical Instrument Co., Ltd. (China), IntroMedic Co., Ltd. (Republic of Korea), SonoScape Medical Corporation (China), Shanghai AOHUA Photoelectricity Endoscope Co., Ltd. (China), Ottomed (India), Kimberly-Clark Corporation (US), and Shaili Endoscopy (India)
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=170242954 [https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=170242954&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=ercpmarket]
Media Contact
Company Name: MarketsandMarkets Trademark Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=endoscopic-retrograde-cholangiopancreatographyercp-market-worth-20-billion-by-2026]
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.prnewswire.com/news-releases/endoscopic-retrograde-cholangiopancreatographyercp-market-worth-2-0-billion-by-2026--exclusive-report-by-marketsandmarkets-301504102.html
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Endoscopic Retrograde Cholangiopancreatography/ERCP Market worth $2.0 billion by 2026 here
News-ID: 3635416 • Views: …
More Releases from ABNewswire

Abby Yoga Studio Expands with Private Yoga Therapy Sessions
Certified Yoga Therapy instructor offers tailored Iyengar-based practices for health needs.
Image: https://www.abnewswire.com/upload/2025/10/f6b927744919d106273aa8b6f23c144c.jpg
Abbotsford, BC - Abby Yoga Studio has introduced private yoga therapy sessions, focusing on personalized assessments and adapted practices for individuals or small groups. Applying Iyengar yoga therapy principles, these one-on-one or limited-group classes address physical and emotional challenges, integrating mind-body healing to restore natural function.
Led by Eileen Millar, a Level Three certified Iyengar teacher and C-IAYT yoga therapist,…

Zil Money Launches ZilRemit as Dedicated International Payment Platform
New Standalone Platform Offers Seamless, Low-Cost Global Payments for Businesses and Personal Use, with Easy App Access and Faster Transaction Processing.
Image: https://www.abnewswire.com/upload/2025/10/491fa4dc34bd8bd434ab18aeac2e7e4f.jpg
TYLER, TX, USA - Oct 09, 2025 - Zil Money, a leading B2B payment platform, today announced the launch of ZilRemit, a dedicated platform for its international payment services. The new platform provides a focused identity for the company's high-speed, low-cost global payment solution, enabling businesses and individuals to…

Shashishekhar Ramagundam: Driving Innovation in AI and Content Discovery at ORCI …
Image: https://www.abnewswire.com/upload/2025/10/be0969e168c2d58f071b39a1d5c5c91e.jpg
Shashishekhar Ramagundam [https://www.linkedin.com/in/shashishekhar-ramagundam-051a1233b] is a computer scientist and senior IEEE member whose career has centered on advancing Machine Learning, artificial intelligence (AI) and scalable content delivery. His research and professional responsibilities directly address critical challenges in streaming media, recommendations, and enterprise-level data security, impacting both academic progress and industry practices.
Educational and Professional Background
Ramagundam earned a master's degree in computer science from Troy University, Alabama, in 2014, with academic strengths…

Conceivable's Proven Fertility Platform Delivers 260% Increase in Natural Concep …
Conceivable, the comprehensive women's health technology platform, has demonstrated remarkable clinical results with its virtual care approach, increasing the likelihood of natural conception by 260% for couples struggling with infertility. The company's integrated model combines fertility coaching, nutrition, culinary support, mental health services, and data science to address the root causes of infertility through personalized, evidence-based interventions.
Conceivable is revolutionizing fertility care with a virtual platform that has achieved what many…
More Releases for ERCP
North America ERCP and PTC Devices Market Expected to Grow at 8.1% CAGR
Introduction
Biliary and pancreatic disorders such as gallstones, strictures, bile duct cancers, and pancreatitis represent significant healthcare challenges in North America. Diagnostic and therapeutic interventions like Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) have become indispensable in managing these conditions.
Both procedures require advanced devices - including endoscopes, catheters, guidewires, stents, and balloon dilators - designed for precision and minimally invasive treatment. Rising prevalence of gastrointestinal (GI) cancers, an aging…
EU5 ERCP and PTC Devices Market to Reach USD 1.5 Billion by 2034
Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) are essential diagnostic and therapeutic procedures used to treat conditions affecting the biliary and pancreatic ducts, such as gallstones, tumors, strictures, and obstructions. ERCP is a non-surgical procedure that combines endoscopy and fluoroscopy to evaluate the pancreatic and bile ducts, while PTC is used in cases where ERCP is not feasible, allowing direct visualization of the bile ducts via a needle…
ERCP Device Market Size And Global Industry Forecast 2034
"The Endoscopic Retrograde Cholangiopancreatography (ERCP) device market is currently valued at approximately $1.2 billion in 2024. The market is projected to grow significantly, reaching an estimated $2.4 billion by 2034, reflecting a robust Compound Annual Growth Rate (CAGR) of 7.4% during the forecast period from 2025 to 2034."
Exactitude Consultancy., Ltd. released a research report titled "ERCP Device Market". This report covers the global ERCP Device market sales, sales volume, price,…
ERCP Catheter Market: Size, Share, Growth, Analysis, Key Players, Revenue, Growt …
ERCP Catheter Market
The global ERCP Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for ERCP Catheter is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for ERCP Catheter is…
Asia-Pacific ERCP Devices Market: Navigating Growth and Innovation
The Asia-Pacific endoscopic retrograde cholangiopancreatography devices market report provides details of market share, new developments, and impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario, contact us for an Analyst Brief. Our team will help you create a…
Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Size to Cross $1,87 …
𝐀𝐜𝐜𝐨𝐫𝐝𝐢𝐧𝐠 𝐭𝐨 𝐭𝐡𝐞 𝐫𝐞𝐩𝐨𝐫𝐭 𝐩𝐮𝐛𝐥𝐢𝐬𝐡𝐞𝐝 𝐛𝐲 𝐀𝐥𝐥𝐢𝐞𝐝 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡, 𝐭𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐄𝐧𝐝𝐨𝐬𝐜𝐨𝐩𝐢𝐜 𝐑𝐞𝐭𝐫𝐨𝐠𝐫𝐚𝐝𝐞 𝐂𝐡𝐨𝐥𝐚𝐧𝐠𝐢𝐨𝐩𝐚𝐧𝐜𝐫𝐞𝐚𝐭𝐨𝐠𝐫𝐚𝐩𝐡𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐠𝐞𝐧𝐞𝐫𝐚𝐭𝐞𝐝 $1.21 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 2019, 𝐚𝐧𝐝 𝐢𝐬 𝐞𝐱𝐩𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐠𝐞𝐧𝐞𝐫𝐚𝐭𝐞 $1.87 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2027, 𝐰𝐢𝐭𝐧𝐞𝐬𝐬𝐢𝐧𝐠 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 5.6% 𝐟𝐫𝐨𝐦 2019 𝐭𝐨 2027. 𝐓𝐡𝐞 𝐫𝐞𝐩𝐨𝐫𝐭 𝐨𝐟𝐟𝐞𝐫𝐬 𝐚𝐧 𝐞𝐱𝐭𝐞𝐧𝐬𝐢𝐯𝐞 𝐚𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐨𝐟 𝐜𝐡𝐚𝐧𝐠𝐢𝐧𝐠 𝐦𝐚𝐫𝐤𝐞𝐭 𝐭𝐫𝐞𝐧𝐝𝐬, 𝐤𝐞𝐲 𝐬𝐞𝐠𝐦𝐞𝐧𝐭𝐬, 𝐭𝐨𝐩 𝐢𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭 𝐩𝐨𝐜𝐤𝐞𝐭𝐬, 𝐯𝐚𝐥𝐮𝐞 𝐜𝐡𝐚𝐢𝐧, 𝐜𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐥𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞, 𝐚𝐧𝐝 𝐫𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐬𝐜𝐞𝐧𝐚𝐫𝐢𝐨.
Endoscopy is a clinical process to observe body tissue or internal…